SCHEMBL31023943

SCHEMBL31023943

OCc1ccc2c(c1)COCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 1/20 0.46
CYP3A4 P08684 5/20 0.40
CYP2D6 P10635 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
BAD Q92934 1/20 0.38
PDE5A O76074 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 2/20 0.36
GAA P10253 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC6A4 P31645 1/20 0.35
MAPT P10636 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
CALM1 P0DP23 1/20 0.35
INSR P06213 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10845738 1.00 SLC5A2 (0.46) SLC5A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL700254 0.86 CYP3A4 (0.40) SLC5A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL12188952 0.82 PARP1 (0.44) SLC5A2CYP3A4CYP2D6NPC1RAB9A
SCHEMBL10843817 0.82 SLC5A2 (0.43) SLC5A2CYP3A4CYP2D6TAAR1CYP1A2
SCHEMBL18648047 0.78 TAAR1 (0.47) SLC5A2CYP3A4CYP2D6TAAR1GAA
SCHEMBL21514918 0.78 SLC5A2 (0.38) SLC5A2CYP3A4CYP2D6RAB9ATAAR1
SCHEMBL22356500 0.78 MIF (0.40) SLC5A2CYP3A4TAAR1ALDH1A1CYP1A2
SCHEMBL1721517 0.78 SLC5A2 (0.38) SLC5A2CYP3A4TAAR1ALDH1A1CYP1A2
SCHEMBL11696212 0.78 CYP4F2 (0.38) CYP3A4CYP2D6NPC1RAB9ABAD
SCHEMBL30792604 0.76 CYP3A4 (0.55) SLC5A2CYP3A4RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed